Recent Quotes
My Watchlist
Indicators
OGJ 150 Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

26.65 +0.04 (+0.14%)
Streaming Delayed Price Updated: 1:52 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,805,511
Open 26.54
Bid (Size) 26.64 (5,800)
Ask (Size) 26.65 (4,700)
Prev. Close 26.61
Today's Range 26.23 - 26.70
52wk Range 20.91 - 27.94
Shares Outstanding 5,606,688,356
Dividend Yield 6.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology
On March 6, 2026, Moderna, Inc. (NASDAQ: MRNA) remains the centerpiece of biotech conversations following a staggering 14% surge in its share price earlier this week. For a company that became a... 
Via Finterra
Topics Initial Public Offering Intellectual Property
News headline image
China Clears Weight-Loss Shot As Pfizer Enters Crowded Market ↗
China approves ecnoglutide weight-loss injection linked to Pfizer after trial shows up to 15.4% average weight reduction in adults. 
Via Benzinga

Performance

YTD
+5.8%
+5.8%
1 Month
+3.4%
+3.4%
3 Month
+3.7%
+3.7%
6 Month
+8.6%
+8.6%
1 Year
+2.7%
+2.7%

More News

Read More
News headline image
Moderna Settles High-Stakes LNP Patent War with $2.25 Billion Agreement
Via MarketMinute
Topics Intellectual Property Lawsuit
News headline image
Argus Turns Bullish On Pfizer, Highlights GLP-1 And Oncology Pipeline ↗
Via Talk Markets
News headline image
Moderna’s Renaissance: Why MRNA Surged 16% as the mRNA Platform Enters the Oncology Era
Via Finterra
Topics Intellectual Property
News headline image
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today ↗
Via The Motley Fool
Topics Intellectual Property
TechMediaBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Appoints Bat-Sheva Noy as Vice President of Global Sales
Via Investor Brand Network
News headline image
The Dividend Safe Harbor: 2 Stocks to Watch ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Higher Income or Ironclad Safety? VCIT vs. IEI ↗
Via The Motley Fool
Topics Bonds ETFs
News headline image
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
Via Finterra
Topics Economy Initial Public Offering Retirement
News headline image
Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need ↗
Via The Motley Fool
News headline image
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Here's Why I Won't Touch Teva Pharmaceutical With a 10‑Foot Pole ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Big Tech’s Heavy Lifting: S&P 500 Q4 Earnings Surpass 8% Growth Amid AI Capex Anxiety
Via MarketMinute
Topics Artificial Intelligence Economy Electric Vehicles
News headline image
The Implementation Pivot: How Accenture Defied the ‘SaaS-pocalypse’ with a Massive AI Rebound
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Industrial Renaissance: Sector Surges 27% in Q4 2025 as Healthcare and Consumer Discretionary Lag
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
Via MarketMinute
Topics Artificial Intelligence ETFs
News headline image
Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?
Via Barchart.com
Topics Stocks
News headline image
The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines
Via Finterra
Topics Economy
News headline image
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Amneal (AMRX) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? ↗
Via Stocktwits
Topics Earnings

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 26.65
When was Pfizer last traded?
The last trade of Pfizer was at 03/06/26 01:52 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 149.40B
How many shares of Pfizer are outstanding?
Pfizer has 149B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>